Zobrazeno 1 - 10
of 16
pro vyhledávání: '"MR Luizon"'
Autor:
L Nascimento, NF Silva, KA Boy, R Tognon-Ribeiro, LM Mendonça, APP Santos, CV Rodrigues, RR Sales, PSAS Gerheim, MR Luizon
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S39-S40 (2024)
Sickle cell disease (SCD) is an autosomal recessive monogenic disorder that modifies the adult hemoglobin and results in multiple clinical phenotypes. Increases in fetal hemoglobin (HbF) has clinical benefits by reducing the clinical severity of SCD.
Externí odkaz:
https://doaj.org/article/0cb73f11f24d485a95d1653f7477f943
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S645-S646 (2024)
Sickle cell anemia (SCA) is a monogenic disease characterized by HbSS genotype with a complex pathophysiology. Fetal hemoglobin(HbF) is the major modifier of clinical phenotypes, and increased HbF levels inhibit polymerization of HbS and ameliorate c
Externí odkaz:
https://doaj.org/article/190e9cf6dac5428d88383b4df9cf964b
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S615- (2024)
Introdução/objetivos: O gene da Enzima Cistationina Beta Sintase (CBS) está localizado no braço q do cromossomo 21 e seu produto realiza a conversão de homocisteína em cistationina. A mutação 844ins68 desse gene adiciona o risco do desenvolvi
Externí odkaz:
https://doaj.org/article/ebf3cbfff97941deb3e8b2678593a1b5
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S276-S277 (2021)
Fetal Hemoglobin (HbF) is a major modifier of clinical events in patients with sickle cell anemia (SCA). Hydroxyurea (HU) improves their clinical course by raising HbF level. There is variability in the response to HU treatment among SCA patients. Ge
Externí odkaz:
https://doaj.org/article/058daa60e2cc4430a2df4c7690b7868f
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S286-S287 (2021)
A hemoglobina fetal (HbF) é uma das mais importantes moduladoras do fenótipo da anemia falciforme (AF) por inibir a polimerização da HbS, mecanismo molecular primário na cascata de eventos fisiopatológicos da AF. Polimorfismos no íntron 2 do g
Externí odkaz:
https://doaj.org/article/d4020b19f1814d5f9a109e828bab4756
Autor:
AC Palei, J Cruz, J Chaguri, J Peracoli, M Romao-Veiga, V Ribeiro-Vasques, R Cavalli, P Nunes, MR Luizon, VC Sandrim
Publikováno v:
The American Journal of the Medical Sciences. 365:S334-S335
Publikováno v:
Drug Week; 11/8/2024, p871-871, 1p
Publikováno v:
Hematology Week; 11/4/2024, p208-208, 1p
Autor:
de Miranda, J A, Lacchini, R, Belo, V A, Lanna, C M M, Sertorio, J T, Luizon, M R, Tanus-Santos, J E
Publikováno v:
Journal of Human Hypertension. Feb2015, Vol. 29 Issue 2, p140-140. 1p.
Autor:
Luizon, M R1, Palei, A C T2, Sandrim, V C3, Amaral, L M1, Machado, J S R4, Lacchini, R1, Cavalli, R C4, Duarte, G4, Tanus-Santos, J E1
Publikováno v:
Pharmacogenomics Journal. Dec2014, Vol. 14 Issue 6, p535-541. 7p.